 G Protein-coupled receptors
|
|
Ion channels
|
|
Nuclear receptors
|
|
Protein kinases
|
|
Cytokines and receptors
|
|
Cell surface molecules and ligands
|
|
Transporters
|
|
 Enzymes
|
Oxidoreductases (EC1)
|
Dehydrogenases [EC:1.1.1.-]
|
ADH [HSA:124 125 126] [KO:K13951]
|
AKR1B1 [HSA:231] [KO:K00011]
|
 D02323 Tolrestat (USAN/INN)
D01688 Epalrestat (JP18/INN) <JP>
D01715 Risarestat (INN)
D01842 Fidarestat (JAN/INN)
D02328 Zopolrestat (USAN/INN)
D02835 Alrestatin sodium (USAN)
D03803 Lidorestat (USAN)
D03805 Minalrestat (USAN/INN)
D03806 Ponalrestat (USAN/INN)
D03807 Zenarestat (USAN/INN)
D05893 Sorbinil (USAN/INN)
D06403 Ranirestat (JAN/INN)
D12384 Govorestat (USAN/INN)
D12390 Caficrestat (USAN/INN)
|
LDHA [HSA:3939] [KO:K00016]
|
HMGCR [HSA:3156] [KO:K00021]
|
IDH [HSA:3417 3418] [KO:K00031]
|
IDH1 [HSA:3417] [KO:K00031]
|
IDH1* [HSA_VAR:3417v1] [HSA:3417] [KO:K00031]
|
IDH2 [HSA:3418] [KO:K00031]
|
IDH2* [HSA_VAR:3418v1] [HSA:3418] [KO:K00031]
|
HSD3B [HSA:3283 3284] [KO:K00070]
|
HSD11B1 [HSA:3290] [KO:K15680]
|
IMPDH [HSA:3614 3615] [KO:K00088]
|
Oxidases [EC:1.1.3.-]
|
Dehydrogenases [EC:1.2.1.-]
|
Dehydrogenases [EC:1.3.-.-]
|
Amine oxidases [EC:1.4.3.-]
|
Dihydrofolate reductase [EC:1.5.1.3]
|
NAD(P)H dehydrogenase [EC:1.6.5.2]
|
Peroxidase [EC:1.11.1.-]
|
Peroxygenase [EC:1.11.2.-]
|
Dioxygenases [EC:1.13.11.-]
|
Prolyl 4-hydroxylase [EC:1.14.11.2]
|
HIF hydroxylase [EC:1.14.11.29]
|
Nitic oxide synthase [EC:1.14.13.39]
|
Cytochrome P450 [EC:1.14.14.-]
|
Other monooxygenases [EC:1.14.16.- 1.14.17.- 1.14.18.-]
|
Prostaglandin synthase [EC:1.14.99.1]
|
Histone demethylase [EC:1.14.99.66]
|
Superoxide dismutase [EC:1.15.1.1]
|
Xanthine dehydrogenase/oxidase [EC:1.17.1.4 1.17.3.2]
|
Ribonucleoside-diphosphate reductase [EC:1.17.4.1]
|
Vitamin-K-epoxide reductase [EC:1.17.4.4]
|
Thyroxine 5'-deiodinase [EC:1.21.99.4]
|
Transferases (EC2)
|
Hydrolases (EC3)
|
Lyases (EC4)
|
Isomerases (EC5)
|
Ligases (EC6)
|
|
Nucleic acids
|
|
Not elsewhere classified
|
Target-based Classification of Drugs